A partially modified retro-inverso pseudopeptide modulates the cytokine profile of CTL specific for an influenza virus epitope

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 200-208

  Ostankovitch, Marina ^a   Guichard, Gilles ^b   Connan, Francine ^a   Muller, Sylviane ^b   Chaboissier, Aude ^a   Hoebeke, Johan ^b   Choppin, Jeannine ^a   Briand, Jean Paul ^b   Guillet, Jean Gérard ^a  

^a INSTITUT COCHIN   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PSEUDOPEPTIDE;

ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNOGENICITY; IMMUNOTHERAPY; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; SUPPRESSOR CELL;

CELL LINE; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; HLA-A2 ANTIGEN; HUMANS; INFLUENZA A VIRUS; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; VIRAL MATRIX PROTEINS;

EID: 0031803276     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Madden, D. R. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587.
2. Bjorkman, P. J., M. A. Saper, B. Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506.
3. Janeway, C. A. 1995. Ligands for the T-cell receptor: hard time for avidity models. Immunol. Today 16:223.
4. Cantrell, D. 1996. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14:259.
5. Sloan-Lancaster, J., and P. M. Allen. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1.
6. Fauchère, J. L., and C. Thurieau. 1992. Evaluation of the stability of peptides and pseudopeptides as a tool in peptide drug design. Adv. Drug Res. 23:127.
7. Briand, J. P., N. Benkirane, G. Guichard, J. F. E. Newman, M. H. V. Van Regenmortel, F. Brown, and S. Muller. 1997. A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies. Proc. Natl. Acad. Sci. USA 94:12545.
8. Benkirane, N., G. Guichard, M. H. V. Van Regenmortel, J. P. Briand, and S. Muller. 1995. Cross-reactivity of antibodies to retro-inverso peptidomimetics with the parent protein histone H3 and chromatin core particle. J. Biol. Chem. 270:11921.
9. Benkirane, N., G. Guichard, J. P. Briand, and S. Muller. 1996. Exploration of requirements for peptidomimetic immune recognition: antigenic and immunogenic properties of reduced peptide bond pseudopeptide analogues of a histone hexapeptide. J. Biol. Chem. 271:33218.
10. Guichard, G., N. Benkirane, G. Zeder-Lutz, M. H. V. Van Regenmortel, J. P. Briand, and S. Muller. 1994. Antigen mimicry of natural L-peptides with retro-inverso peptidomimetics. Proc. Natl. Acad. Sci. USA 91:9765.
11. Verdoliva, A., M. Ruvo, G. Cassani, and G. Fassina. 1995. Topological mimicry of cross-reacting enantiomeric peptide antigens. J. Biol. Chem. 270:30422.
12. Mézière, C., M. Viguier, H. Dumortier, R. Lo-Man, C. Leclerc, J. G. Guillet, J. P. Briand, and S. Muller. 1997. In vivo T helper cell response to retro-inverso peptidomimetics. J. Immunol. 159:3230.
13. Guichard, G., F. Connan, R. Graff, M. Ostankovitch, S. Muller, J. G. Guillet, J. Choppin, and J. P. Briand. 1996. Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2. J. Med. Chem. 39:2030.
14. Connan, F., F. Hlavac, J. Hoebeke, J. G. Guillet, and J. Choppin. 1994. A simple assay for detection of peptides promoting the assembly of HLA class I molecules. Eur. J. Immunol. 24:777.
15. Martinon, F., E. Gomard, C. Hannoun, and J. P. Levy. 1990. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides. Eur. J. Immunol. 20:2171.
16. Gotch, F., J. Rothbard, K. Howland, A. Townsend, and A. J. McMichael. 1987. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 326:881.
17. Benveniste, O., B. Vaslin, F. Villinger, R. Le Grand, A. Ansari, and D. Dormont. 1996. Cytokine mRNA levels in unmanipulated (ex vivo) and in vitro stimulated monkey PBMCs using a semi-quantitative RT-PCR and high sensitivity fluorescence-based detection strategy. Cytokine 8:32.
18. + memory T cells. J. Exp. Med. 186:859.
19. Madden, D. R., D. N. Garboczi, and D. C. Wiley. 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75:693.
20. Chorev, M., and M. Goodman. 1993. A dozen years of retro-inverso peptidomimetics. Acc. Chem. Res. 26:266.
21. Parker, K. C., M. Bednarek, L. K. Hull, U. Utz, B. Cunningham, H. J. Zweerinck, W. E. Biddison, and J. E. Coligan. 1992. Sequence motifs important for peptide binding to the human MHC class I molecule HLA-A2. J. Immunol. 149:2580.
22. Rognan, D., N. Zimmermann. J. Günther, and G. Folkers. 1992. Molecular dynamics study of a complex between the human histocompatibility antigen HLA-A2 and the IMP58-66 nonapeptide from the influenza virus matrix protein. Eur. J. Biochem. 208:101.
23. Guidotti, L., and F. V. Chisari. 1996. To kill or to cure: options in host defense against viral infection. Curr. Opin. Immunol. 8:478.
24. + tumor infiltrating lymphocytes. J. Exp. Med. 173:647.
25. + T cells in response to antagonist ligands. J. Exp. Med. 184:149.
26. Madrenas, J., R. L. Wange, J. Wang, N. Isakov, L. E. Samelson, and R. N. Germain. 1995. ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267:515.
27. Matsui, K., J. J. Boniface, P. Steffner, P. Reay, and M. M. Davis. 1994. Kinetics of T cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T cell responsiveness. Proc. Natl. Acad. Sci. USA 91:12862.
28. Lyons, D. S., S. A. Lieberman, J. Hampl, J. J. Boniface, Y. H. Chien, L. J. Berg, and M. M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5:53.
29. Janeway, C. A. J., U. Dianzani, P. Portoles, S. Rath, E. P. Reich, J. Rojo, J. Yagi, and D. B. Murphy. 1989. Cross-linking and conformation change in T cell receptors: role in activation and in repertoire selection. Cold Spring Harbor Symp. Quant. Biol. 54:657.
30. Yoon, S. T., U. Dianzani, K. Bottomly, and C. A. Janeway. 1994. Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity 1:563.